Why invest now?
With proof of concept and product-market fit, this sector's growth is a natural point for investors chasing exceptional returns and decreased risk.
Savvy investors understand the significance of incorporating social, environmental, and
corporate governance (ESG) investments into their portfolios. Over the last 3 to 5 years, the
alternative medical canatherapeutics sector has been uniquely linked to these values.
Investors are increasingly applying these non-financial factors to their analysis in
determining material risks and growth opportunities
Healthcare Revolution
So why now? The sector is now beginning to recognise its full potential. The industry will more than double in size over the next five years. Estimates foresee the legalised market size across Europe reaching 89 million users.
Our FREE Information Document will give you an insight into why
this natural plant is changing our approach to healthcare.
Mother nature’s green leaf not only provides a viable alternative to big pharma healthcare with the treatment of Epilepsy, Multiple Sclerosis and ADHD. It is also well documented that its sister leaf; is the only perennial renewable natural resource capable of supplying
the world's paper, textile, transportation, and energy needs while reducing pollution, rebuilding the soil, and cleansing the atmosphere.
Key Points
Founded in 2019 by an experienced Management Team.
Fully licenced and compliant businesses.
Physical presence in Portugal, Lesotho, South Africa & Colombia
Ethical therapies for many conditions
Global shift, disrupting prescriptive healthcare
100% natural and offers significant therapeutic benefits
EU state healthcare systems serve a population of 760m people
The industry will more than double in size in the next five years.
“Germany will constitute over half of the European market until 2024 and will be worth over €840 million by the end of the forecast period.”
Source: Prohibition Partners